New Clinical Study for Longstanding Type 1 Diabetes to Evaluate Residual Beta Cell Function

A new study has been launched that seeks to evaluate differences in the immune systems of those who have had type 1 diabetes for five or more years and who still make some insulin, versus those with type 1 diabetes who do not make insulin. It will also establish a blood bank for future studies of type 1 diabetes. Led by pediatric diabetes program director Steve Gitelman, MD, and endocrine fellow Hilary Thomas, MD, the study seeks volunteers who are:

  • eight (8) years of age or older who have had type 1 diabetes for five or more years;
  • have a hemoglobin A1c less than 9.5%.

Dr. Thomas is excited to be leading this clinical study since she knows what it is like to have longstanding type 1 diabetes -- her sister was diagnosed at two and has been living with the disease for 34 years. "The commitment that my sister has had to make to take care of herself on a daily basis never ceases to amaze me." Dr. Thomas completed her undergraduate training at Dartmouth, her medical degree at Emory University, and her medical internship and residency at Johns Hopkins. She joined UCSF in 2010.